Skip to main content
Matthew Reilley, MD, Oncology, Charlottesville, VA

MatthewJamesReilleyMD

Oncology • Charlottesville, VA

Gastrointestinal Cancer

Director, Phase 1 Clinical Trial Program Director, GI Medical Oncology Research Assistant Professor of Medicine, University of Virginia School of Medicine Department of Medicine, Division of Hematology/Oncology

Join to view full profile

Dr. Reilley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Reilley's full profile

Already have an account?

  • Office

    1300 Jefferson Park Avenue
    PO Box 800716
    Charlottesville, VA 22908
    Phone+1 434-297-5504

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2016 - 2017
  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2014 - 2017
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 2012 - 2014
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemInternship, Internal Medicine, 2011 - 2012
  • The Warren Alpert Medical School of Brown University
    The Warren Alpert Medical School of Brown UniversityClass of 2011, M.D.
  • Dartmouth Medical School
    Dartmouth Medical SchoolM.D, 2006 - 2008
  • Washington and Lee University
    Washington and Lee UniversityB.S., B.A., 2002 - 2006

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2017 - 2026
  • TX State Medical License
    TX State Medical License 2014 - 2017
  • PA State Medical License
    PA State Medical License 2011 - 2014
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • Phase 1 trial of TLR9 agonist lefitolimod in combination with CTLA-4 checkpoint inhibitor ipilimumab in advanced tumors. 
    2019 ASCO Annual Meeting - 6/1/2019

Professional Memberships

Dr. Matthew Reilley, Dr. Matthew Reilley, MD, Dr. M Reilley, Dr. Matthew James Reilley